Treatment group | Control group | p | |
---|---|---|---|
Number of patients | 96 | 96 | |
Diabetes mellitus type II | 12/96 (13 %) | 14/96 (14 %) | p = 0.8 |
Polycystic kidney disease | 6/96 (6 %) | 8/96 (8 %) | p = 0.6 |
Hypertension | 23 (24 %) | 20 (21 %) | p = 0.6 |
Male/female | 40/56 (42 %) | 44/52 (46 %) | p = 0.6 |
Age | 54 ± 15 | 57 ± 13 | p = 0.14 |
eGFR (CKD-EPI), ml/min/1.73 m2 | 23 ± 9 | 25 ± 11 | p = 0.17 |
CKD stage 3B/4/5 | 28/43/25 (29 %/45 %/26 %) | 33/37/26 (34 %/39 %/27 %) | p = 0.6 |
Albumin, g/dl | 4.1 ± 0.5 | 4.2 ± 0.4 | p = 0.13 |
Calcium, mmol/l | 2.28 ± 0.16 | 2.26 ± 0.14 | p = 0.4 |
Phosphate, mmol/l | 1,27 ± 0,26 | 1,21 ± 0,24 | p = 0.10 |
Sodium, mmol/l | 140 ± 3 | 141 ± 3 | p = 0.02 |
Cholesterol, mmol/l | 5.8 ± 1.2 | 5.5 ± 1.0 | p = 0.06 |
Triglycerides, mmol/ | 2.06 ± 0.98 | 1.85 ± 1.11 | p = 0.19 |
Hemoglobin, g/dl | 12.4 ± 1.4 | 12.2 ± 1.3 | p = 0.3 |
Serum Fe, μmol/l | 13 ± 5 | 12 ± 4 | p = 0.13 |
CRP, mg/dl | 0.1 ÷ 0.6 | 0.2 ÷ 0.8 | p = 0.13 |
Mean proteinuria, g/day | 1.18 ÷ 2.56 | 1.24 ÷ 2.42 | p = 0.06 |
Maximal proteinuria, g/day | 1.49 ÷ 4.94 | 1.56 ÷ 5.72 | p = 0.11 |
Number of patients with hypertension (>140/90 mmHg) | 31/96 (32 %) | 34/96 (35 %) | p = 0.5 |
Systolic blood pressure | 137 ± 20 | 139 ± 22 | p = 0.5 |
Diastolic blood pressure | 83 ± 12 | 81 ± 11 | p = 0.2 |